No 307 Hospital Of Military Medical Science Academy Of The Pla

Beijing, China

No 307 Hospital Of Military Medical Science Academy Of The Pla

Beijing, China
SEARCH FILTERS
Time filter
Source Type

Song Y.,Qingdao University | Zhang H.,Qingdao University | Song S.,No 307 Hospital Of Military Medical Science Academy Of The Pla | Jiang Z.,No 307 Hospital Of Military Medical Science Academy Of The Pla
Chinese Journal of Clinical Oncology | Year: 2011

Objective: To discuss the expression and location of the transcription factor Fra-1 in benign and malignant human breast tissues. Methods: Fra-1 expression was investigated immunohistochemically in neoplastic breast diseases ranging from benign fibroadenomas to very aggressive undifferentiated carcinomas. The correlation between Fra-1 expression and other indicators of breast carcinoma prognosis (ER, PR, and ErbB2 receptors) were analyzed. Results: The nuclei of all neoplastic breast tissue cells, both in benign and malignant breast tissues, were immunoreactive to anti-Fra-1 antibodies. In 85% of the benign tumors (17/20), the immunoreactivity of the anti-Fra-1 antibodies was exclusively restricted to the nuclei. In three cases (3/20, 15%), focal unequivocal cytoplasmic staining was also observed. Strong positive nuclear staining for Fra-1 was easily seen in all types of breast carcinomas. However, concomitant nuclear-cytoplasmic immunoreactivity was observed in all types of breast carcinomas. A clear shift in Fra-1 immunoreactivity, from an exclusively nuclear to a simultaneous nuclear and cytoplasmic localization, was observed in 90.2% (37/41) of breast carcinomas. No inverse relationship was observed between Fra-1 and the ER and PR protein levels in the malignant tumors. The relative Fra-1 expression level was not correlated with ErbB2 expression. Conclusion: The overall expression, pattern, and intensity of the Fra-1 protein were correlated with breast oncogenesis. Fra-1 overexpression, leading to persistently high cytoplasmic accumulation, may play a role in breast carcinogenesis.


Zhong K.,No 307 Hospital Of Military Medical Science Academy Of The Pla | Su H.,No 307 Hospital Of Military Medical Science Academy Of The Pla | Xiao X.,No 307 Hospital Of Military Medical Science Academy Of The Pla | Liu J.,No 307 Hospital Of Military Medical Science Academy Of The Pla | And 5 more authors.
Chinese Journal of Clinical Oncology | Year: 2014

Objective: The effect and side effect of the dose-adjusted EPOCH regimen were evaluated perspectively for the preliminarily diagnosed angioimmunoblastic T-cell lymphoma.Methods: Nine cases of untreated angioimmunoblastic T-cell lymphoma were diagnosed and enrolled in our department from September 2008 to September 2012. All patients received dose-adjusted EPOCH regimen as first-line chemotherapy.Results: The median age of 9 patients was 54 years. The male-to-female ratio was 2:1. About 88.9% of all patients were at Ann Arbor stage III/IV, and 77.8% presented with B symptoms. Anemia was found in 66.7% of 9 patients, and lactate dehydrogenase elevated in 55.6% of patients. After an average of 4.7 cycles of chemotherapy of dose-adjusted EPOCH regimen, the complete remission rate was 22.2%, and the total response rate was 66.7%. With a median follow-up of 20 months, the 4-year progression-free survival rate was 11.1%, and the overall survival rate was 33.3%. The median survival time was 19 months. The most common adverse events of EPOCH chemotherapy were hematologic toxicity. Grades 3-4 neutropenia and thrombocytopenia were reported in 77.8% and 33.3% of patients. Febrile neutropenia was observed in 44.4% of patients. Non-treatment-related mortality was also noted.Conclusion: The results of our research showed no clear benefit of treating preliminarily diagnosed angioimmunoblastic T-cell lymphoma with dose-adjusted EPOCH regimen. The main adverse events were hematologic toxicity and could be tolerated.

Loading No 307 Hospital Of Military Medical Science Academy Of The Pla collaborators
Loading No 307 Hospital Of Military Medical Science Academy Of The Pla collaborators